Tideglusib is an irreversible GSK3β inhibitor, which reduces tau phosphorylation and prevents apoptotic death in human neuroblastoma cells and murine primary neurons (Domínguez et al., 2012). This evidence concerns the gene MAPT and neuroblastoma.